Biocryst Pharmaceuticals (BCRX) stock forecast for 2022 – 2027

Are you interested in BioCryst Pharmaceuticals, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the BCRX stock price in 2022-2027. Is BCRX a good long term stock? When should I take profit in Biocryst Pharmaceuticals stock? Buy or sell stock? Will BCRX stock price go up? What are analysts’ forecasts for BCRX stock?
Forecst.com predicts future values using technical analysis of a large number of analytical parameters. BCRX stock returns are also predicted based on historical data.

According to our research, BCRX stock is a acceptable long-term investment. BCRX share price has been in a positive cycle for the past year. BioCryst Pharmaceuticals, Inc. stock trend is positive.

Biocryst Pharmaceuticals company info

Industry Biotechnology
Address 4505 Emperor Boulevard, Durham, NC, 27703, United States
Website https://www.biocryst.com

Forecasting

52 Week High: 17.4298 USD
52 Week Low: 14.8808 USD
1 Year Forecast: 16.7468 USD
5 Year Forecast: 22.4988 USD

Agilent Technologies info

Market Cap: 2.76B
52 Week Change: 4.991%
52 Week High: 18.48 USD
52 Week Low: 8.86 USD
Beta: 1.56727
50 Day Moving Average: 13.84
90 Day Moving Average: 13.107
200 Day Moving Average: 14.39
Resistance Level: 15.9192
Pivot Point: 15.1371
Support Level: 14.4936
Enterprise Value: 3,067,405,312
Forward P/E: -14.87
Forward EPS: -1
Profit Margin: -198.88%
Shares Outstanding: 179,936,000
EBITDA: -16.84
Held Percent Institutions: 59.22%
PEG Ratio (5Y): -0.67
Trailing EPS: -1.27

Biocryst Pharmaceuticals stock forecasts for 2022-2027

DateOpen PriceClose PriceChange

Biocryst Pharmaceuticals Stock Forecast for 2022

March 2022 14.85 14.28 -3.84%
April 2022 14 15 7.14%
May 2022 15.3 15 -1.96%
June 2022 15.3 14.85 -2.94%
July 2022 14.7 15.68 6.67%
August 2022 16.16 15.68 -2.97%
September 2022 16.32 16 -1.96%
October 2022 15.84 16 1.01%
November 2022 16.32 16 -1.96%
December 2022 16 15.84 -1%

Biocryst Pharmaceuticals Stock Forecast for 2023

January 2023 16.32 15.68 -3.92%
February 2023 16 15.84 -1%
March 2023 15.84 15.68 -1.01%
April 2023 16.16 16.32 0.99%
May 2023 15.84 17.17 8.4%
June 2023 15.84 17.34 9.47%
July 2023 17.17 18 4.83%
August 2023 18.18 18 -0.99%
September 2023 18 17.17 -4.61%
October 2023 17 17 0%
November 2023 17 16.66 -2%
December 2023 17.34 18 3.81%

Biocryst Pharmaceuticals Stock Forecast for 2024

January 2024 18.36 17.82 -2.94%
February 2024 17.82 18.18 2.02%
March 2024 18.36 16.83 -8.33%
April 2024 17.17 17.64 2.74%
May 2024 17.82 18.18 2.02%
June 2024 18.36 17.64 -3.92%
July 2024 18.81 19.19 2.02%
August 2024 19.38 19 -1.96%
September 2024 18.81 18.62 -1.01%
October 2024 18.62 19.38 4.08%
November 2024 19.38 18.62 -3.92%
December 2024 19.38 18.81 -2.94%

Biocryst Pharmaceuticals Stock Forecast for 2025

January 2025 18.81 18.81 0%
February 2025 19 18.62 -2%
March 2025 19.38 18.62 -3.92%
April 2025 19.38 19.19 -0.98%
May 2025 19 20.2 6.32%
June 2025 19.8 19.6 -1.01%
July 2025 19.6 20.58 5%
August 2025 20.58 21 2.04%
September 2025 21.42 20 -6.63%
October 2025 19.6 20 2.04%
November 2025 20 19.6 -2%
December 2025 19.8 21.21 7.12%

Biocryst Pharmaceuticals Stock Forecast for 2026

January 2026 20.58 21.21 3.06%
February 2026 21.42 21 -1.96%
March 2026 20.58 20.58 0%
April 2026 20.79 21 1.01%
May 2026 21 21 0%
June 2026 21.42 21.56 0.65%
July 2026 22.22 21.56 -2.97%
August 2026 21.78 21.56 -1.01%
September 2026 22.22 21.56 -2.97%
October 2026 22.44 22.22 -0.98%
November 2026 22 22.22 1%
December 2026 22.44 22.22 -0.98%

Biocryst Pharmaceuticals Stock Forecast for 2027

January 2027 23.23 22.22 -4.35%